Subscriber Content Read Preview
An FDA advisory panel's draft report about menthol cigarettes helps make the case for Lorillard shares.
Subscriber Content Read Preview
Subscriber Content Read Preview
Subscriber Content Read Preview
Shares of Warren Buffett's investment vehicle could head higher as the company's latest annual report underscores its financial strength.
Subscriber Content Read Preview
Subscriber Content Read Preview
Subscriber Content Read Preview
Fund manager Tom Cameron favors a motley collection of stocks ranging from McDonald's to Danish drug maker Novo Nordisk.
Subscriber Content Read Preview
Subscriber Content Read Preview
Subscriber Content Read Preview
Howard S. Frank sold 120,000 shares of the cruise company.
Subscriber Content Read Preview
Subscriber Content Read Preview
Subscriber Content Read Preview
J.P. Morgan says Marvell will see continued wireless strength.
Subscriber Content Read Preview
Subscriber Content Read Preview
Subscriber Content Read Preview
Poor use of capital more than offsets operational excellence for tech giant's shareholders.
Subscriber Content Read Preview
Subscriber Content Read Preview
Subscriber Content Read Preview
Berkshire Hathaway, Interpublic, Medicis and Nationwide Health all rose.
Subscriber Content Read Preview
Subscriber Content Read Preview
Subscriber Content Read Preview
Enjoy it while it lasts; what could follow is a bust in 2012 and a nasty stock sell-off later this year.
Subscriber Content Read Preview
Subscriber Content Read Preview
Subscriber Content Read Preview
In a bearish sign for the market, more than a fifth of stocks in the blue-chip index failed to hold on to recent breakouts.
Subscriber Content Read Preview
Subscriber Content Read Preview
Subscriber Content Read Preview
Buy calls on the networking stock to take advantage of the possibility of some good near-term news.
Subscriber Content Read Preview
Subscriber Content Read Preview
Subscriber Content Read Preview
The energy firm has recently outperformed peers by 35%.
Subscriber Content Read Preview
Subscriber Content Read Preview
If history is any judge, the stock advance that began in March 2009 is hitting valuation levels that are cause for concern.
Subscriber Content Read Preview
Subscriber Content Read Preview
The stock gained 8% in midday trading after a prediction that it could gain at least 50% in the next 12 months.
Subscriber Content Read Preview
Subscriber Content Read Preview